Cardiomatics provides a cloud-based AI tool that automates ECG interpretation and generates reports in minutes, detecting roughly 20 heart abnormalities. The startup announced a $3.2M seed raise (plus a $1M non-equity grant) to expand use of its ECG-reading automation technology. Its software integrates with more than 25 ECG monitoring devices and is used by over 700 customers across 10+ countries, having commercially analysed more than 3 million hours of ECG signals. The company says its development dataset contains over 10 billion heartbeats from approximately 100,000 patients, with 90% of data used for training and 10% for validation and monthly algorithm checks; clients also check performance in clinical practice. Cardiomatics received European medical device certification in 2018 and says it closely monitors evolving EU medical-device and AI regulations. It plans to use the seed proceeds for product development, scaling its AI technology, expanding in existing markets and preparing to enter new markets, including pursuing FDA certification and US entry.

Total raised

$3M

Funding rounds

2

Latest round

Grant

Latest activity

Aug 2021